Latest Breaking News On - Collegium pharmaceutical company profile - Page 1 : comparemela.com

Collegium Pharmaceutical, Inc (NASDAQ:COLL) CFO Colleen Tupper Sells 19,710 Shares

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) CFO Colleen Tupper sold 19,710 shares of the company’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $34.21, for a total transaction of $674,279.10. Following the completion of the sale, the chief financial officer now directly owns 130,845 […]

United statesPiper sandlerColleen tupperNeedham companyProshare advisorsSecurities exchange commissionPricet rowe associates incIllinois municipal retirement fundCollegium pharmaceutical incTexas permanent school fund corpSummerhaven investment managementCollegium pharmaceutical company profileCollegium pharmaceuticalGet free reportExchange commissionShare advisors

Aigen Investment Management LP Takes $338,000 Position in Collegium Pharmaceutical, Inc (NASDAQ:COLL)

Aigen Investment Management LP Takes $338,000 Position in Collegium Pharmaceutical, Inc (NASDAQ:COLL)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerGareng bohlinCollegium pharmaceutical company profileCollegium pharmaceutical incPacer advisors incJohnson investment counsel incSummerhaven investment managementNeedham companyAigen investment managementCollegium pharmaceuticalFree reportFinancial marketsHaven investment managementInvestment counselGet free reportDirector garen

Collegium Pharmaceutical, Inc (NASDAQ:COLL) Given Consensus Recommendation of Hold by Analysts

Collegium Pharmaceutical, Inc (NASDAQ:COLL) Given Consensus Recommendation of Hold by Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerVanguard group incNeedham companyCollegium pharmaceutical incPacer advisors incDimensional fund advisorsCollegium pharmaceutical company profileInvesco ltdCollegium pharmaceuticalGet free reportFund advisorsGet freeCollegium pharmaceutical daily

Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by Piper Sandler

Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by Piper Sandler
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesPiper sandlerSg americas securitiesCollegium pharmaceutical company profileCollegium pharmaceutical incLos angeles capital managementAllspring global investments holdingsNeedham companyCollegium pharmaceuticalFree reportGet free reportGlobal investments holdingsAngeles capital managementCollegium pharmaceutical daily

Collegium Pharmaceutical (COLL) Scheduled to Post Quarterly Earnings on Thursday

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) will post its quarterly earnings data after the market closes on Thursday, May 9th. Analysts expect Collegium Pharmaceutical to post earnings of $1.37 per share for the quarter. Collegium Pharmaceutical has set its FY 2024 guidance at EPS.Investors that wish to listen to the company’s conference call can […]

Piper sandlerNeedham companyCollegium pharmaceutical incJefferies financial groupCollegium pharmaceutical company profileCollegium pharmaceuticalGet free reportFinancial groupCollegium pharmaceutical dailyNasdaq coll